Literature DB >> 1367278

Growth rate control in fed-batch cultures of recombinant Saccharomyces cerevisiae producing hepatitis B surface antigen (HBsAg).

M B Gu1, M H Park, D I Kim.   

Abstract

A recombinant Saccharomyces cerevisiae producing hepatitis B surface antigen (HBsAg) exhibited growth-associated product formation. By controlling the medium feed rate, based on the calculated amount of medium required for 1 h, a constant specific growth rate was obtained in the range of 0.12-0.18 h-1. In order to prolong the exponential growth phase, the medium feed rate was increased exponentially. A fed-batch cultivation method based on the production kinetics of batch culture enhanced HBsAg production ten times more than in batch culture. The reason for the increase can be explained by the fact that the production of HBsAg is expressed as an exponential function of time when the specific growth rate is controlled to a constant value in growth-associated product formation kinetics. In the scale-up of this culture to 91, the specific growth rate could also be maintained constant and the HBsAg production trend was similar to that in a 1-1 culture. However, ethanol accumulation occurred at a late stage in fed-bach culture. Ethanol produced was not reutilized and inhibited further cell growth.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1367278     DOI: 10.1007/bf00180634

Source DB:  PubMed          Journal:  Appl Microbiol Biotechnol        ISSN: 0175-7598            Impact factor:   4.813


  9 in total

1.  Kinetic study of instability of recombinant plasmid pPLc23trpAl in E. coli using two-stage continuous culture system.

Authors:  R Siegel; D D Ryu
Journal:  Biotechnol Bioeng       Date:  1985-01       Impact factor: 4.530

2.  A perspective on the application of genetic engineering: stability of recombinant plasmid.

Authors:  T Imanaka; S Aiba
Journal:  Ann N Y Acad Sci       Date:  1981       Impact factor: 5.691

3.  Synthesis and assembly of hepatitis B virus surface antigen particles in yeast.

Authors:  P Valenzuela; A Medina; W J Rutter; G Ammerer; B D Hall
Journal:  Nature       Date:  1982-07-22       Impact factor: 49.962

4.  Computer-aided baker's yeast fermentations.

Authors:  H Y Wang; C L Cooney; D I Wang
Journal:  Biotechnol Bioeng       Date:  1977-01       Impact factor: 4.530

5.  Controlled fed-batch fermentation of recombinant Saccharomyces cerevisiae to produce hepatitis B surface antigen.

Authors:  J H Hsieh; K Y Shih; H F Kung; M Shiang; L Y Lee; M H Meng; C C Chang; H M Lin; S C Shih; S Y Lee; T Y Chow; T Y Feng; T T Kuo; K B Choo
Journal:  Biotechnol Bioeng       Date:  1988-07-20       Impact factor: 4.530

6.  Fed batch culture of Saccharomyces cerevisiae: a perspective of computer control to enhance the productivity in baker's yeast cultivation.

Authors:  S Aiba; S Nagai; Y Nishizawa
Journal:  Biotechnol Bioeng       Date:  1976-07       Impact factor: 4.530

7.  Effect of growth rate and expression level on plasmid stability in Saccharomyces cerevisiae.

Authors:  C Parker; D Dibiasio
Journal:  Biotechnol Bioeng       Date:  1987-02       Impact factor: 4.530

8.  Controlled expression and purification of human immune interferon from high-cell-density fermentations of Saccharomyces cerevisiae.

Authors:  J C Fieschko; K M Egan; T Ritch; R A Koski; M Jones; G A Bitter
Journal:  Biotechnol Bioeng       Date:  1987-06       Impact factor: 4.530

9.  Hepatitis B vaccine produced in yeast.

Authors:  G A Bitter; K M Egan; W N Burnette; B Samal; J C Fieschko; D L Peterson; M R Downing; J Wypych; K E Langley
Journal:  J Med Virol       Date:  1988-06       Impact factor: 2.327

  9 in total
  4 in total

1.  Plasmid stability and kinetics of continuous production of glucoamylase by recombinant Saccharomyces cerevisiae in an airlift bioreactor.

Authors:  Peter M Kilonzo; Argyrios Margaritis; Maurice A Bergougnou
Journal:  J Ind Microbiol Biotechnol       Date:  2009-06-06       Impact factor: 3.346

Review 2.  Bioprocessing data for the production of marine enzymes.

Authors:  Sreyashi Sarkar; Arnab Pramanik; Anindita Mitra; Joydeep Mukherjee
Journal:  Mar Drugs       Date:  2010-04-19       Impact factor: 5.118

Review 3.  Physiological and technological aspects of large-scale heterologous-protein production with yeasts.

Authors:  M C Hensing; R J Rouwenhorst; J J Heijnen; J P van Dijken; J T Pronk
Journal:  Antonie Van Leeuwenhoek       Date:  1995       Impact factor: 2.271

Review 4.  Virus-like particles as a highly efficient vaccine platform: diversity of targets and production systems and advances in clinical development.

Authors:  Natasha Kushnir; Stephen J Streatfield; Vidadi Yusibov
Journal:  Vaccine       Date:  2012-11-06       Impact factor: 3.641

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.